News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
338,792 Results
Type
Article (20398)
Company Profile (128)
Press Release (318266)
Multimedia
Podcasts (75)
Webinars (11)
Section
Business (106456)
Career Advice (883)
Deals (18698)
Drug Delivery (97)
Drug Development (51205)
Employer Resources (79)
FDA (7828)
Job Trends (7839)
News (187694)
Policy (17523)
Tag
Academia (778)
Accelerated approval (3)
Adcomms (17)
Allergies (46)
Alliances (28142)
ALS (60)
Alzheimer's disease (671)
Antibody-drug conjugate (ADC) (102)
Approvals (7840)
Artificial intelligence (153)
Autoimmune disease (17)
Automation (7)
Bankruptcy (180)
Best Places to Work (5624)
BIOSECURE Act (13)
Biosimilars (100)
Biotechnology (57)
Bladder cancer (41)
Brain cancer (19)
Breast cancer (119)
Cancer (1153)
Cardiovascular disease (122)
Career advice (717)
Career pathing (21)
CAR-T (56)
Cell therapy (159)
Cervical cancer (6)
Clinical research (43134)
Collaboration (505)
Compensation (198)
Complete response letters (23)
COVID-19 (1124)
CRISPR (28)
C-suite (166)
Cystic fibrosis (61)
Data (1280)
Decentralized trials (2)
Denatured (19)
Depression (27)
Diabetes (151)
Diagnostics (1876)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (83)
Drug pricing (116)
Drug shortages (30)
Duchenne muscular dystrophy (63)
Earnings (39634)
Editorial (34)
Employer branding (10)
Employer resources (73)
Events (49594)
Executive appointments (482)
FDA (8530)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (341)
Gene editing (56)
Generative AI (19)
Gene therapy (157)
GLP-1 (613)
Government (1904)
Grass and pollen (3)
Guidances (81)
Healthcare (6103)
Huntington's disease (14)
IgA nephropathy (21)
Immunology and inflammation (94)
Indications (19)
Infectious disease (1207)
Inflammatory bowel disease (91)
Inflation Reduction Act (8)
Influenza (26)
Intellectual property (59)
Interviews (116)
IPO (7444)
IRA (45)
Job creations (2449)
Job search strategy (649)
Kidney cancer (7)
Labor market (29)
Layoffs (288)
Leadership (16)
Legal (4155)
Liver cancer (32)
Lung cancer (172)
Lymphoma (93)
Machine learning (5)
Management (30)
Manufacturing (235)
MASH (55)
Medical device (2149)
Medtech (2152)
Mergers & acquisitions (11536)
Metabolic disorders (532)
Multiple sclerosis (53)
NASH (20)
Neurodegenerative disease (55)
Neuropsychiatric disorders (23)
Neuroscience (1015)
NextGen: Class of 2025 (2425)
Non-profit (993)
Now hiring (23)
Obesity (332)
Opinion (192)
Ovarian cancer (35)
Pain (78)
Pancreatic cancer (42)
Parkinson's disease (88)
Partnered (11)
Patents (156)
Patient recruitment (53)
Peanut (16)
People (33966)
Pharmaceutical (74)
Pharmacy benefit managers (22)
Phase I (13531)
Phase II (18256)
Phase III (14640)
Pipeline (874)
Policy (133)
Postmarket research (1621)
Preclinical (4759)
Press Release (29)
Prostate cancer (66)
Psychedelics (16)
Radiopharmaceuticals (162)
Rare diseases (258)
Real estate (3206)
Recruiting (29)
Regulatory (12724)
Reports (23)
Research institute (865)
Resumes & cover letters (139)
Rett syndrome (1)
RNA editing (2)
RSV (25)
Schizophrenia (64)
Series A (60)
Series B (37)
Service/supplier (7)
Sickle cell disease (37)
Special edition (16)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2035)
State (2)
Stomach cancer (9)
Supply chain (55)
Tariffs (52)
The Weekly (54)
Vaccines (295)
Venture capitalists (30)
Weight loss (249)
Women's health (14)
Worklife (8)
Date
Today (72)
Last 7 days (501)
Last 30 days (1561)
Last 365 days (16769)
2025 (6202)
2024 (17871)
2023 (19886)
2022 (26175)
2021 (26984)
2020 (25206)
2019 (20413)
2018 (15835)
2017 (17413)
2016 (16382)
2015 (19045)
2014 (14977)
2013 (12689)
2012 (13585)
2011 (13950)
2010 (12841)
Location
Africa (420)
Alabama (25)
Alaska (1)
Arizona (69)
Arkansas (8)
Asia (25140)
Australia (3295)
California (2777)
Canada (1181)
China (356)
Colorado (108)
Connecticut (105)
Delaware (82)
Europe (52075)
Florida (491)
Georgia (59)
Idaho (16)
Illinois (267)
India (20)
Indiana (181)
Iowa (3)
Japan (133)
Kansas (65)
Kentucky (18)
Louisiana (3)
Maine (4)
Maryland (394)
Massachusetts (2356)
Michigan (51)
Minnesota (148)
Mississippi (1)
Missouri (29)
Montana (10)
Nebraska (11)
Nevada (19)
New Hampshire (8)
New Jersey (1110)
New Mexico (21)
New York (821)
North Carolina (529)
North Dakota (2)
Northern California (1184)
Ohio (85)
Oklahoma (5)
Oregon (21)
Pennsylvania (661)
Puerto Rico (12)
Rhode Island (18)
South America (614)
South Carolina (5)
Southern California (1135)
Tennessee (40)
Texas (367)
United States (11072)
Utah (61)
Virginia (97)
Washington D.C. (47)
Washington State (232)
Wisconsin (25)
338,792 Results for "leo pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LEO Pharma Announces Publication of Head-to-Head DELTA FORCE Study Results in The Lancet
April 24, 2025
·
7 min read
Press Releases
LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis
May 9, 2025
·
5 min read
Press Releases
LEO Pharma Survey: Dermatology Providers Say Chronic Hand Eczema Is Widely Misunderstood and Inadequately Managed
March 5, 2025
·
5 min read
Press Releases
LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025
March 10, 2025
·
10 min read
Press Releases
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
January 20, 2025
·
8 min read
Press Releases
DEBRA Research and LEO Pharma Announce Strategic Partnership to Advance Treatments for Rare Skin Disease
February 5, 2025
·
1 min read
Press Releases
LEO Pharma Meets Primary Endpoint in Phase 3 DELTA China Trial with Anzupgo® (delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE)
February 27, 2025
·
9 min read
Press Releases
LEO Pharma’s Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland
November 14, 2024
·
11 min read
Press Releases
LEO Pharma Achieves Positive DELTA TEEN Trial Results with Anzupgo® (delgocitinib) Cream in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)
February 5, 2025
·
9 min read
Press Releases
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
January 13, 2025
·
6 min read
1 of 33,880
Next
